Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Liposomal Bupivacaine for Pain Control of Split Thickness Skin Graft Donor Sites

NCT03854344 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT03854344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03854344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Liposomal Bupivacaine for Pain Control of Split Thickness Skin Graft Donor Sites
Lead sponsor
University of Kansas Medical Center
Phase
Phase 4
Overall status
Completed
Start date
March 18, 2019
Completion date
October 27, 2025
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burns, pain, postoperative